EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
How EY can help
-
The full power of the EY network helps health care players shore up today’s performance — and capture tomorrow’s opportunities. Here’s how.
Read more -
Washington Council Ernst & Young (WCEY) is a tax, legislative and regulatory group within Ernst & Young LLP that combines the power of a leading professional services organization with the on-the-ground knowledge, personal relationships and attention to detail of a boutique Washington-insider firm.
Read more
Pressure on provider reimbursement rates
Regardless of payers’ operational readiness and growth strategy, the provider community will begin to feel significant financial strain as the number of uninsured individuals increases, pandemic relief funds run dry and pre-pandemic budgetary cuts resume. Further, impending changes to provider staffing and training requirements that were relaxed during the pandemic may also contribute to increased labor costs for the provider community, especially amid the ongoing health care staffing shortage.
As such, health plans must proactively anticipate and develop mitigation strategies for providers who may use upcoming negotiations to help offset financial losses stemming from the conclusion of PHE policies and pandemic-related financial support. Given the anticipated influx of Marketplace enrollment volume, this will be especially important for payers heading into the 2024 and 2025 application, bidding and filing seasons.
Redefine benefit design and cost sharing
One mitigation strategy against arbitrary provider rate increases may be to evaluate whether it makes sense for payers to continue to reimburse for nontraditional, cost-effective care delivery models to which consumers have grown accustomed and upon which providers have relied heavily for reimbursement during the pandemic. Developing product offerings that preserve many of the attractive pandemic-era benefits offered and cost-sharing strategies may help the provider community continue to receive valuable sources of revenue that would otherwise dry up.
Despite cost pressures, continuing COVID-19-era product designs popular with enrollees may also help payers protect valuable premium revenue in an increasingly competitive environment by retaining existing membership and support enterprise growth objectives by attracting new sources of membership moving forward. Examples of these product designs include waiving cost shares for select products and services, preserving telehealth benefits and continuing to allow patients to receive virtual or home-based care where clinically appropriate and where regulations allow.
Beyond COVID-19-era benefits, there’s another emerging opportunity for health plans to develop and offer products that leverage value-based insurance design (VBID) principles specifically tailored for enrollees with one or more chronic conditions to also address increasing medical spend. VBID plans are intended to reduce the financial barriers for members with chronic conditions to receive high-value preventative care services, minimize the incidence of uncontrolled medical events and drive long-term medical cost savings for both patients and payers. Given the anticipated influx in Marketplace coverage expected over the next 12 months, health plans that develop these innovative offerings may further find success with condition-specific, VBID-oriented products catered to enrollees who seek personalized coverage options that best meet their financial and clinical needs.